69
Participants
Start Date
November 30, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
November 30, 2012
DPK-060
DPK-060 2% ear drops were administered as 3 applications per day into the outer ear by use of a single-dose pipette (0.3 mL/pipette) for 7 days. In case clinical symptoms remained after 7 days of treatment, the treatment period was extended by another 3 days with 3 applications per day.
Placebo for DPK-060 ear drops
Placebo for DPK-060 ear drops were administered as 3 applications per day into the outer ear by use of a single-dose pipette (0.3 mL/pipette) for 7 days. In case clinical symptoms remained after 7 days of treatment, the treatment period was extended by another 3 days with 3 applications per day.
Curakliniken, Malmo
Hallands Sjukhus, Halmstad
Hagakliniken, Gothenburg
Me3+ Clinical Trials, Gothenburg
ProbarE, Lund
S3 Clinical Research Center, Vällingby, Stockholm
Värmdö vårdcentral, Stockholm
Lead Sponsor
Collaborators (1)
Pergamum AB
INDUSTRY
DermaGen AB
INDUSTRY